The Lasting Benefit of Immune Checkpoint Inhibitors
Study suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after...
Progress Against Cancer
Study suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after...
Study supports the use of immune checkpoint inhibitors in an understudied population.
An implantable device, along with an infusion of microbubbles, helps increase chemotherapy concentrations for brain cancer.
Some women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
Researchers focus on assessing quality of life and toxicity risks in people with breast cancer in a session at...
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...